NAVATA KING: Open Payments
NPI 1760230957 · IRMO, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,310 in 68 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $337 · 2025 $1,310
Food & beverage: $1,310
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $250 |
| ABBVIE INC. | 14 | $191 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $173 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Recor Medical Inc | 3 | $69 |
| Merck Sharp & Dohme LLC | 3 | $66 |
| Stryker Corporation | 2 | $58 |
| Amgen Inc. | 3 | $47 |
| Lundbeck LLC | 2 | $39 |
| Aimmune Therapeutics, Inc. | 2 | $37 |
Products named: Kerendia, Ozempic, REXULTI, VRAYLAR, Wegovy, QULIPTA, Paradise Ultrasound Renal Denervation System, VERQUVO.
Industry payments across SC — which companies pay providers there.
